Novartis AG (LTS:0QM7) Cash Flow for Dividends: CHF-6,899.70 Mil (TTM As of Mar. 2026)


What is Novartis AG Cash Flow for Dividends?

Novartis AG LTS:0QM7 82 Cash Flow for Dividends is CHF-6,899.70 Mil as of Mar. 2026. GuruFocus rates LTS:0QM7 with a GF Score™ of 82/100. The stock has 7 warning signs investors should review.

Novartis AG's cash flow for dividends for the three months ended in Mar. 2026 was CHF-4,878.90 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2026 was CHF-6,899.70 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Novartis AG's quarterly payment of dividends stayed the same from Sep. 2025 (CHF0.00 Mil) to Dec. 2025 (CHF0.00 Mil) but then increased from Dec. 2025 (CHF0.00 Mil) to Mar. 2026 (CHF-4,878.90 Mil).

Novartis AG's annual payment of dividends increased from Dec. 2023 (CHF-6,274.12 Mil) to Dec. 2024 (CHF-6,797.56 Mil) but then declined from Dec. 2024 (CHF-6,797.56 Mil) to Dec. 2025 (CHF-6,230.16 Mil).

Novartis AG Cash Flow for Dividends Related Terms

Novartis AG Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Novartis AG's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novartis AG Cash Flow for Dividends Chart

Novartis AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6,785.93 -6,992.59 -6,274.12 -6,797.56 -6,230.16

Novartis AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4,712.24 -2,020.80 0.00 0.00 -4,878.90

Novartis AG Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF-6,899.70 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of CHF-6,899.70 Mil mean?
Novartis AG (LTS:0QM7) has a Cash Flow for Dividends of CHF-6,899.70 Mil as of Mar. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Novartis AG and its competitors.
Is Novartis AG's Cash Flow for Dividends too high?
Novartis AG's current Cash Flow for Dividends is CHF-6,899.70 Mil. Overall, Novartis AG has a GF Score™ of 82/100, reflecting its overall financial health beyond just this single metric.
How does Novartis AG's Cash Flow for Dividends compare to LLY and JNJ?
Novartis AG's Cash Flow for Dividends of CHF-6,899.70 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Drug Manufacturers company?
A good Cash Flow for Dividends depends on the Drug Manufacturers industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Novartis AG and its competitors. Novartis AG's current Cash Flow for Dividends is CHF-6,899.70 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novartis AG stock overvalued right now?
Novartis AG (LTS:0QM7) has a current Cash Flow for Dividends of CHF-6,899.70 Mil. The current Cash Flow for Dividends is CHF-6,899.70 Mil. Novartis AG's overall GF Score™ is 82/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Novartis AG (LTS:0QM7), the current Cash Flow for Dividends is CHF-6,899.70 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Novartis AG Business Description

Address Lichtstrasse 35, Basel, CHE, 4056
Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.